Overview and Scope
Small molecule innovator CDMO refers to a pharmaceutical division offering small-molecule drug development and manufacturing contract services. It is used in clinical trials to obtain early relative bioavailability information.
Sizing and Forecast
The small molecule innovator cdmo market size has grown strongly in recent years. It will grow from $51.84 billion in 2023 to $56.13 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising demand for outsourcing, increasing complexity of small molecule drugs, increasing focus on time-to-market, cost pressures on pharma companies, stringent regulatory requirements.
The small molecule innovator cdmo market size is expected to see strong growth in the next few years. It will grow to $76.46 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to rise in personalized medicine and targeted therapies, increased focus on green chemistry and sustainability, demand for faster time-to-market for new drugs, expansion of biopharmaceutical pipeline, emergence of advanced therapies. Major trends in the forecast period include rise of virtual and remote development models, increased collaboration and partnerships in the pharma industry, expansion of cdmo services to emerging markets, utilization of single-use technologies in manufacturing, evolution of cdmos into strategic development partners.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/small-molecule-innovator-cdmo-global-market-report
Segmentation & Regional Insights
The small molecule innovator cdmo market covered in this report is segmented –
1) By Product: Small Molecule Active Pharmaceutical Ingredient(API), Small Molecule Drug Product
2) By Stage: Preclinical, Clinical, Commercial
3) By Therapeutic: Cardiovascular Disease, Oncology, Respiratory Disorders, Neurology, Metabolic Disorders, Infectious Disease, Other Therapeutics
4) By Customer: Pharmaceutical, Biotechnology
Asia-Pacific was the largest region in the small molecule innovator CDMO market in 2023. The regions covered in the small molecule innovator cdmo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12178&type=smp
Major Driver Impacting Market Growth
The rising prevalence of chronic diseases is expected to propel the growth of the small-molecule innovator CDMO market going forward. Chronic diseases are diseases that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Small molecule innovator CDMO provides services and manufactures chronic disease medicines for pharmaceutical and biotech companies. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, it was projected that in the US by the year 2050, the number of individuals aged 50 years and older who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, the rising prevalence of chronic diseases is propelling the small-molecule innovator CDMO market.
Key Industry Players
Major companies operating in the small molecule innovator cdmo market report are Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Evonik Industries AG, Lonza Group Ltd. , Labcorp Drug Development, Catalent Inc., Wuxi AppTec Co. Ltd., Asymchem, Siegfried holdings, Recipharm AB, Almac Sciences Ltd., Curia Global Inc., Cambrex Corporation, Piramal Pharma Ltd., Hovione, Corden Pharma GmbH, Alcami Corporation, Lifecore Biomedical Inc., NovaTech LLC, Mikart LLC, Kymanox Corporation, August Bioservices LLC, Lyophilization Technology Inc., LGM Pharma LLC, INCOG BioPharma Services
The small molecule innovator cdmo market report table of contents includes:
1. Executive Summary
2. Small Molecule Innovator CDMO Market Characteristics
3. Small Molecule Innovator CDMO Market Trends And Strategies
4. Small Molecule Innovator CDMO Market – Macro Economic Scenario
5. Global Small Molecule Innovator CDMO Market Size and Growth
…
32. Global Small Molecule Innovator CDMO Market Competitive Benchmarking
33. Global Small Molecule Innovator CDMO Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Small Molecule Innovator CDMO Market
35. Small Molecule Innovator CDMO Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
